• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SRx Health Solutions Appoints Sammy Dorf to Board of Directors

    11/10/25 8:00:00 AM ET
    $FLGC
    $SRXH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $FLGC alert in real time by email

    TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors.

    Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company.

    With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy brings an unmatched combination of legal expertise, entrepreneurial insight, and operational execution. His career has been defined by his ability to envision and deliver large-scale growth initiatives that balance community engagement, regulatory excellence, and brand innovation.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company's risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

    Company Contact:

    SRx Health Solutions, Inc.

    Kent Cunningham, Chief Executive Officer

    Investor Contact:

    KCSA Strategic Communications

    Valter Pinto, Managing Director

    T: 212-896-1254

    [email protected]



    Primary Logo

    Get the next $FLGC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FLGC
    $SRXH

    CompanyDatePrice TargetRatingAnalyst
    Flora Growth Corp.
    $FLGC
    11/25/2024$4.00Buy
    Aegis Capital
    Flora Growth Corp.
    $FLGC
    10/13/2021$10.00Buy
    Roth Capital
    Flora Growth Corp.
    $FLGC
    6/23/2021$6.00Buy
    MKM Partners
    More analyst ratings

    $FLGC
    $SRXH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cunningham Kent Douglas

    4 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    4/3/26 11:04:57 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 3 filed by new insider Cunningham Kent Douglas

    3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    4/3/26 11:01:45 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 4 filed by Conway Simon Alexander Malcolm

    4 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    4/3/26 8:29:22 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $FLGC
    $SRXH
    SEC Filings

    View All

    SRX Health Solutions Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SRx Health Solutions, Inc. (0001471727) (Filer)

    4/17/26 12:08:22 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form S-4 filed by SRX Health Solutions Inc.

    S-4 - SRx Health Solutions, Inc. (0001471727) (Filer)

    4/14/26 5:18:08 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRX Health Solutions Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - SRx Health Solutions, Inc. (0001471727) (Filer)

    3/18/26 8:52:15 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $FLGC
    $SRXH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Starke Clifford bought $6,455 worth of shares (6,795 units at $0.95), increasing direct ownership by 13,324% to 6,846 units (SEC Form 4)

    4 - Flora Growth Corp. (0001790169) (Issuer)

    9/17/24 10:17:39 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Wolkin Harold bought $24,255 worth of shares (25,000 units at $0.97) (SEC Form 4)

    4 - Flora Growth Corp. (0001790169) (Issuer)

    9/11/24 5:43:51 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO Starke Clifford bought $48 worth of shares (51 units at $0.95), increasing direct ownership by 0.01% to 474,046 units (SEC Form 4)

    4 - Flora Growth Corp. (0001790169) (Issuer)

    9/6/24 5:25:10 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    $SRXH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aegis Capital initiated coverage on Flora Growth with a new price target

    Aegis Capital initiated coverage of Flora Growth with a rating of Buy and set a new price target of $4.00

    11/25/24 8:07:10 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Roth Capital initiated coverage on Flora Growth with a new price target

    Roth Capital initiated coverage of Flora Growth with a rating of Buy and set a new price target of $10.00

    10/13/21 9:00:51 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MKM Partners initiated coverage on Flora Growth with a new price target

    MKM Partners initiated coverage of Flora Growth with a rating of Buy and set a new price target of $6.00

    6/23/21 5:36:01 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLGC
    $SRXH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson

    NORTH PALM BEACH, Fla., April 17, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today released a letter to shareholders providing an update on the proposed transaction from Eric. M. Jackson, the creator of the EMJX platform. Mr. Jackson will be appointed as an officer of the Company's EMJC subsidiary following the merger. Dear Shareholders, I wanted to take this opportunity to provide an update on our latest progress and the merger agreement between the Company and EMJX. As most of you are aware, the Com

    4/17/26 8:20:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Acquires Shares of Compass Inc. and Increases Investment in Opendoor Technologies Inc.

    SRXH files Form S-4 with SEC in connection with EMJX merger  SRXH provides update on performance through mid-April with an approximate 3.5% gain in hedging pool, driven by EMJX's algorithm, and an approximate gain of 8% in its long treasury investment holdings NORTH PALM BEACH, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced acquiring shares in the open market of Compass Inc. and increasing its investment in Opendoor Technologies Inc. Further to additions to its portfolio,

    4/16/26 8:30:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Returns +5.69% in March 2026 Driven by EMJX Artificial Intelligence (AI) Engine

    +5.69% return for shareholders compares to -4.98% decline on the S&P 500 index SRx Health Board of Directors to consider implementing a quarterly dividend policy based on percentage of profits from portfolio NORTH PALM BEACH, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced returning +5.69% in March 2026 in its hedging pool driven by the EMJX artificial intelligence (AI) engine as compared to a decline of -4.98% on the S&P 500 index. Michael Young, Director of SRx Health, co

    4/7/26 9:05:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $FLGC
    $SRXH
    Financials

    Live finance-specific insights

    View All

    SRx Health Solutions Acquires Shares of Compass Inc. and Increases Investment in Opendoor Technologies Inc.

    SRXH files Form S-4 with SEC in connection with EMJX merger  SRXH provides update on performance through mid-April with an approximate 3.5% gain in hedging pool, driven by EMJX's algorithm, and an approximate gain of 8% in its long treasury investment holdings NORTH PALM BEACH, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced acquiring shares in the open market of Compass Inc. and increasing its investment in Opendoor Technologies Inc. Further to additions to its portfolio,

    4/16/26 8:30:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Returns +5.69% in March 2026 Driven by EMJX Artificial Intelligence (AI) Engine

    +5.69% return for shareholders compares to -4.98% decline on the S&P 500 index SRx Health Board of Directors to consider implementing a quarterly dividend policy based on percentage of profits from portfolio NORTH PALM BEACH, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced returning +5.69% in March 2026 in its hedging pool driven by the EMJX artificial intelligence (AI) engine as compared to a decline of -4.98% on the S&P 500 index. Michael Young, Director of SRx Health, co

    4/7/26 9:05:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRX Health Solutions Inc. Announces Fiscal First Quarter 2026 Results for Quarter Ended December 31, 2025

    Executed Definitive Agreement to Acquire EMJ Crypto Technologies ("EMJX"), a "Gen 2" Digital-Asset Treasury Platform, Anticipated to Close in first half of Calendar 2026  Strengthened Balance Sheet, with $13.1 Million in Cash at Quarter End During and Subsequent to Quarter, Deployed $18 Million Into Bitcoin and Ethereum as part of Digital Treasury Strategy NORTH PALM BEACH, Fla., Feb. 13, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company" or "SRXH"), a pet health and wellness company, today announced its financial results for the fiscal first quarter 2026 for the three-month period ended December 31, 2025. "Q1 FY26 marked a pivotal reset for the Company," s

    2/13/26 4:05:00 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $FLGC
    $SRXH
    Leadership Updates

    Live Leadership Updates

    View All

    SRx Health Solutions Appoints Sammy Dorf to Board of Directors

    TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company. With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy b

    11/10/25 8:00:00 AM ET
    $FLGC
    $SRXH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples

    Flora Growth Corp. Appoints BitGo as Custodian for $0G Treasury

    Fort Lauderdale, Florida--(Newsfile Corp. - October 16, 2025) - Flora Growth Corp. (NASDAQ:FLGC), which is set to rebrand as ZeroStack (the "Company"), the first and largest decentralized AI treasury company, has appointed BitGo Trust Company, Inc. ("BitGo") to provide institutional-grade custody for the Company's $0G treasury.BitGo, the digital asset infrastructure company, has enabled its clients to securely navigate the digital asset space since 2013 by delivering custody, wallets, staking, trading, financing, and settlement services from regulated cold storage. The appointment of BitGo is proof of the Company's focused approach to transparency, security, regulatory compliance and operati

    10/16/25 8:00:00 AM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee

    TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current

    10/1/25 8:00:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $FLGC
    $SRXH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Flora Growth Corp.

    SC 13G/A - Flora Growth Corp. (0001790169) (Subject)

    11/14/24 2:24:54 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care